Breaking News Instant updates and real-time market news.

PRTA

Prothena

$24.87 /

-0.835 (-3.25%)

16:12
04/18/21
04/18
16:12
04/18/21
16:12

Prothena presents Phase 1 study results of PRX004

Prothena presented positive results from the Phase 1 study of PRX004 as part of the Emerging Science Session at the American Academy of Neurology 2021 Virtual Annual Meeting. PRX004 showed favorable results as demonstrated by slowing of neuropathy progression for all 7 evaluable patients at 9 months, including improvement in neuropathy in 3 of the 7 patients, and improved cardiac systolic function for all 7 patients. In this Phase 1 study, PRX004 was found to be generally safe and well tolerated across all dose levels. For all of the evaluable patients, slowing of neuropathy progression was demonstrated by a mean change from baseline in Neuropathy Impairment Score of +1.29 points at 9 months. This compares favorably to a calculated mean change in NIS of +9.2 points at 9 months in untreated and placebo-treated patients with hereditary ATTR peripheral neuropathy based on analysis of published historical data. In addition, the change in NIS for each of these evaluable patients was more favorable than the published historical data. In this highly progressive disease, it was encouraging to see 3 of 7 patients demonstrate improvement in neuropathy with a mean change in NIS of -3.33 points at 9 months. These positive results were observed in patients with or without concomitant use of stabilizer therapy. PRX004 also demonstrated improvement in cardiac systolic function in each of the 7 evaluable patients, with a mean change in GLS of -1.21% at 9 months. For the 3 patients who improved on NIS, GLS improvement was more pronounced, with a mean change of -1.51% at 9 months. Taken together, these positive clinical findings suggest PRX004's depleter mechanism of action can result in benefits in both neuropathy and cardiac function.

  • 24

    Mar

PRTA Prothena
$24.87 /

-0.835 (-3.25%)

03/15/21 Jefferies
Prothena price target raised to $38 from $30 at Jefferies
02/26/21 RBC Capital
Prothena upgraded to Outperform from Sector Perform at RBC Capital
02/26/21 RBC Capital
Prothena upgraded to Outperform from Sector Perform at RBC Capital
02/12/21 Jefferies
Jefferies upgrades 'very cheap' Prothena to Buy, doubles target to $30

TODAY'S FREE FLY STORIES

Hot Stocks
WisdomTree launches WisdomTree Alternative Income Fund » 08:47
05/06/21
05/06
08:47
05/06/21
08:47
WETF

WisdomTree

$7.00 /

-0.02 (-0.28%)

WisdomTree announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WETF WisdomTree
$7.00 /

-0.02 (-0.28%)

WETF WisdomTree
$7.00 /

-0.02 (-0.28%)

04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
04/08/21 Morgan Stanley
Morgan Stanley upgrades WisdomTree to Equal Weight on improved growth outlook
04/08/21 Morgan Stanley
WisdomTree upgraded to Equal Weight from Underweight at Morgan Stanley
03/17/21 Northcoast
WisdomTree downgraded to Neutral from Buy at Northcoast
WETF WisdomTree
$7.00 /

-0.02 (-0.28%)

WETF WisdomTree
$7.00 /

-0.02 (-0.28%)

Hot Stocks
Cryoport, LabConnect announce partnership » 08:47
05/06/21
05/06
08:47
05/06/21
08:47
CYRX

Cryoport

$61.53 /

+6.79 (+12.40%)

LabConnect and Cryoport…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYRX Cryoport
$61.53 /

+6.79 (+12.40%)

CYRX Cryoport
$61.53 /

+6.79 (+12.40%)

03/15/21
Fly Intel: Top five analyst initiations
03/15/21 UBS
Cryoport initiated with a Buy at UBS
03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Needham
Cryoport assumed with a Buy at Needham
CYRX Cryoport
$61.53 /

+6.79 (+12.40%)

  • 21
    Jan
CYRX Cryoport
$61.53 /

+6.79 (+12.40%)

Earnings
Tribune Publishing sees 2021 revenue $685M-$695M, two est. $819.76M » 08:46
05/06/21
05/06
08:46
05/06/21
08:46
TPCO

Tribune Publishing

$17.48 /

-0.01 (-0.06%)

For the full year 2021,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TPCO Tribune Publishing
$17.48 /

-0.01 (-0.06%)

TPCO Tribune Publishing
$17.48 /

-0.01 (-0.06%)

02/18/21 Noble Capital
Tribune Publishing downgraded to Underperform from Market Perform at Noble Capital
02/17/21 Noble Capital
Tribune Publishing downgraded to Market Perform from Outperform at Noble Capital
05/28/20 Huber Research
Tribune Publishing downgraded to Underweight from Overweight at Huber Research
TPCO Tribune Publishing
$17.48 /

-0.01 (-0.06%)

TPCO Tribune Publishing
$17.48 /

-0.01 (-0.06%)

TPCO Tribune Publishing
$17.48 /

-0.01 (-0.06%)

Earnings
Tribune Publishing sees Q2 revenue $172M-$175M » 08:45
05/06/21
05/06
08:45
05/06/21
08:45
TPCO

Tribune Publishing

$17.48 /

-0.01 (-0.06%)

For the second quarter of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TPCO Tribune Publishing
$17.48 /

-0.01 (-0.06%)

TPCO Tribune Publishing
$17.48 /

-0.01 (-0.06%)

02/18/21 Noble Capital
Tribune Publishing downgraded to Underperform from Market Perform at Noble Capital
02/17/21 Noble Capital
Tribune Publishing downgraded to Market Perform from Outperform at Noble Capital
05/28/20 Huber Research
Tribune Publishing downgraded to Underweight from Overweight at Huber Research
TPCO Tribune Publishing
$17.48 /

-0.01 (-0.06%)

TPCO Tribune Publishing
$17.48 /

-0.01 (-0.06%)

TPCO Tribune Publishing
$17.48 /

-0.01 (-0.06%)

Hot Stocks
General Electric acquires molecular imaging agent Zionexa, terms undisclosed » 08:45
05/06/21
05/06
08:45
05/06/21
08:45
GE

General Electric

$13.20 /

+0.07 (+0.53%)

GE Healthcare announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GE General Electric
$13.20 /

+0.07 (+0.53%)

GE General Electric
$13.20 /

+0.07 (+0.53%)

04/29/21 Stephens
AerCap named a Best Idea at Stephens
04/28/21 Deutsche Bank
General Electric price target raised to $15 from $14 at Deutsche Bank
04/27/21 JPMorgan
General Electric should pull back after 'mixed' quarter, says JPMorgan
04/26/21 Lake Street
Desktop Metal to face more competition from GE, says Lake Street
GE General Electric
$13.20 /

+0.07 (+0.53%)

GE General Electric
$13.20 /

+0.07 (+0.53%)

GE General Electric
$13.20 /

+0.07 (+0.53%)

GE General Electric
$13.20 /

+0.07 (+0.53%)

Hot Stocks
Fluidigm announces publication on its mass cytometry technologies » 08:45
05/06/21
05/06
08:45
05/06/21
08:45
FLDM

Fluidigm

$4.86 /

-0.24 (-4.71%)

, AZN

AstraZeneca

$53.64 /

+0.69 (+1.30%)

Fluidigm (FLDM) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FLDM Fluidigm
$4.86 /

-0.24 (-4.71%)

AZN AstraZeneca
$53.64 /

+0.69 (+1.30%)

FLDM Fluidigm
$4.86 /

-0.24 (-4.71%)

02/11/21 Piper Sandler
Fluidigm price target lowered to $8 from $15 at Piper Sandler
12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
11/09/20 Piper Sandler
Buy companies with COVID-19 tests on today's selloff, says Piper Sandler
10/19/20 Piper Sandler
Fluidigm test pact in Texas 'another validation,' says Piper Sandler
AZN AstraZeneca
$53.64 /

+0.69 (+1.30%)

05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
FLDM Fluidigm
$4.86 /

-0.24 (-4.71%)

AZN AstraZeneca
$53.64 /

+0.69 (+1.30%)

AZN AstraZeneca
$53.64 /

+0.69 (+1.30%)

FLDM Fluidigm
$4.86 /

-0.24 (-4.71%)

AZN AstraZeneca
$53.64 /

+0.69 (+1.30%)

AZN AstraZeneca
$53.64 /

+0.69 (+1.30%)

Recommendations
Surgery Partners price target raised to $61 from $54 at RBC Capital » 08:45
05/06/21
05/06
08:45
05/06/21
08:45
SGRY

Surgery Partners

$50.28 /

+1 (+2.03%)

RBC Capital analyst Frank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGRY Surgery Partners
$50.28 /

+1 (+2.03%)

SGRY Surgery Partners
$50.28 /

+1 (+2.03%)

06:28 Today Citi
Surgery Partners price target raised to $58 from $55 at Citi
03/11/21 RBC Capital
Surgery Partners price target raised to $54 from $36 at RBC Capital
12/10/20 Citi
Surgery Partners price target raised to $35 from $28 at Citi
08/07/20 Citi
Surgery Partners price target raised to $23 from $15 at Citi
SGRY Surgery Partners
$50.28 /

+1 (+2.03%)

  • 28
    Jan
Earnings
Tribune Publishing reports Q1 EPS $1.43 vs. ($1.26) last year » 08:45
05/06/21
05/06
08:45
05/06/21
08:45
TPCO

Tribune Publishing

$17.48 /

-0.01 (-0.06%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TPCO Tribune Publishing
$17.48 /

-0.01 (-0.06%)

TPCO Tribune Publishing
$17.48 /

-0.01 (-0.06%)

02/18/21 Noble Capital
Tribune Publishing downgraded to Underperform from Market Perform at Noble Capital
02/17/21 Noble Capital
Tribune Publishing downgraded to Market Perform from Outperform at Noble Capital
05/28/20 Huber Research
Tribune Publishing downgraded to Underweight from Overweight at Huber Research
TPCO Tribune Publishing
$17.48 /

-0.01 (-0.06%)

TPCO Tribune Publishing
$17.48 /

-0.01 (-0.06%)

TPCO Tribune Publishing
$17.48 /

-0.01 (-0.06%)

Options
Largest borrow rate increases among liquid names » 08:45
05/06/21
05/06
08:45
05/06/21
08:45
IRBT

iRobot

$95.31 /

-0.72 (-0.75%)

, WPRT

Westport

$6.44 /

-0.09 (-1.38%)

, DUST

Direxion Daily Gold Miners Bear 3X ETF

$18.15 /

-0.325 (-1.76%)

, ACB

Aurora Cannabis

$8.78 /

+0.11 (+1.27%)

, FTAI

Fortress Transportation

$27.54 /

+0.19 (+0.69%)

, WRAP

Wrap Technologies

$6.15 /

+0.11 (+1.82%)

, CVAC

CureVac

$101.00 /

-8.31 (-7.60%)

, FSR

Fisker

$11.38 /

-0.6 (-5.01%)

, WKHS

Workhorse Group

$10.98 /

-0.21 (-1.88%)

Latest data shows the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IRBT iRobot
$95.31 /

-0.72 (-0.75%)

WPRT Westport
$6.44 /

-0.09 (-1.38%)

DUST Direxion Daily Gold Miners Bear 3X ETF
$18.15 /

-0.325 (-1.76%)

ACB Aurora Cannabis
$8.78 /

+0.11 (+1.27%)

FTAI Fortress Transportation
$27.54 /

+0.19 (+0.69%)

WRAP Wrap Technologies
$6.15 /

+0.11 (+1.82%)

CVAC CureVac
$101.00 /

-8.31 (-7.60%)

FSR Fisker
$11.38 /

-0.6 (-5.01%)

WKHS Workhorse Group
$10.98 /

-0.21 (-1.88%)

IRBT iRobot
$95.31 /

-0.72 (-0.75%)

02/12/21 Northland
iRobot price target raised to $140 from $120 at Northland
02/12/21 Citi
iRobot price target raised to $140 from $95 at Citi
02/11/21 JPMorgan
iRobot upgraded to Overweight from Neutral at JPMorgan
02/11/21 JPMorgan
iRobot upgraded to Overweight from Neutral at JPMorgan
WPRT Westport
$6.44 /

-0.09 (-1.38%)

03/18/21 Lake Street
Lake Street confidence in Westport's China ramp boosted by Weichai deal
03/17/21 H.C. Wainwright
Westport price target raised to $16 from $5 at H.C. Wainwright
02/08/21 Craig-Hallum
Clean Energy price target raised to $25 from $12 at Craig-Hallum
02/08/21 Craig-Hallum
Westport target raised to $24 following Amazon truck order, says Craig-Hallum
DUST Direxion Daily Gold Miners Bear 3X ETF
$18.15 /

-0.325 (-1.76%)

ACB Aurora Cannabis
$8.78 /

+0.11 (+1.27%)

04/28/21 BofA
Aurora Cannabis reinstated with a Neutral at BofA
04/28/21 BofA
Tilray reinstated with a Buy at BofA
04/05/21 CIBC
Aurora Cannabis price target lowered to C$15 from C$18.50 at CIBC
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
FTAI Fortress Transportation
$27.54 /

+0.19 (+0.69%)

03/05/21 B. Riley Securities
Fortress Transportation price target raised to $37 from $31 at B. Riley
03/01/21 Barclays
Fortress Transportation price target raised to $30 from $23 at Barclays
02/23/21 JMP Securities
Fortress Transportation price target raised to $32 from $22 at JMP Securities
02/22/21 B. Riley Securities
Fortress Transportation price target raised to $31 from $27 at B. Riley
WRAP Wrap Technologies
$6.15 /

+0.11 (+1.82%)

04/15/21 Maxim
Wrap Technologies initiated with a Buy at Maxim
04/15/21 Maxim
Wrap Technologies initiated with a Buy at Maxim
CVAC CureVac
$101.00 /

-8.31 (-7.60%)

04/26/21 Credit Suisse
CureVac assumed with an Underperform at Credit Suisse
04/26/21 Guggenheim
CureVac initiated with a Buy at Guggenheim
01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
FSR Fisker
$11.38 /

-0.6 (-5.01%)

04/22/21
Fly Intel: Top five analyst downgrades
04/22/21 Goldman Sachs
Fisker downgraded to Sell from Neutral at Goldman Sachs
04/20/21 Morgan Stanley
Fisker remains 'top ranked' EV related SPAC startup, says Morgan Stanley
04/20/21 BofA
Fisker initiated with a Buy at BofA
WKHS Workhorse Group
$10.98 /

-0.21 (-1.88%)

04/16/21 B. Riley
B. Riley says Workhorse can deliver without Post Office, starts with Buy
04/15/21 B. Riley
Workhorse Group initiated with a Buy at B. Riley
02/24/21
Fly Intel: Top five analyst downgrades
02/24/21 Oppenheimer
Opco downgrades Workhorse after Postal Service snub despite backlog
IRBT iRobot
$95.31 /

-0.72 (-0.75%)

WPRT Westport
$6.44 /

-0.09 (-1.38%)

ACB Aurora Cannabis
$8.78 /

+0.11 (+1.27%)

FTAI Fortress Transportation
$27.54 /

+0.19 (+0.69%)

WRAP Wrap Technologies
$6.15 /

+0.11 (+1.82%)

FSR Fisker
$11.38 /

-0.6 (-5.01%)

WKHS Workhorse Group
$10.98 /

-0.21 (-1.88%)

  • 28
    Jan
  • 22
    Jan
  • 11
    Nov
  • 14
    Aug
WPRT Westport
$6.44 /

-0.09 (-1.38%)

ACB Aurora Cannabis
$8.78 /

+0.11 (+1.27%)

CVAC CureVac
$101.00 /

-8.31 (-7.60%)

FSR Fisker
$11.38 /

-0.6 (-5.01%)

WKHS Workhorse Group
$10.98 /

-0.21 (-1.88%)

IRBT iRobot
$95.31 /

-0.72 (-0.75%)

WPRT Westport
$6.44 /

-0.09 (-1.38%)

ACB Aurora Cannabis
$8.78 /

+0.11 (+1.27%)

CVAC CureVac
$101.00 /

-8.31 (-7.60%)

FSR Fisker
$11.38 /

-0.6 (-5.01%)

WKHS Workhorse Group
$10.98 /

-0.21 (-1.88%)

IRBT iRobot
$95.31 /

-0.72 (-0.75%)

WPRT Westport
$6.44 /

-0.09 (-1.38%)

DUST Direxion Daily Gold Miners Bear 3X ETF
$18.15 /

-0.325 (-1.76%)

ACB Aurora Cannabis
$8.78 /

+0.11 (+1.27%)

FTAI Fortress Transportation
$27.54 /

+0.19 (+0.69%)

WRAP Wrap Technologies
$6.15 /

+0.11 (+1.82%)

CVAC CureVac
$101.00 /

-8.31 (-7.60%)

FSR Fisker
$11.38 /

-0.6 (-5.01%)

WKHS Workhorse Group
$10.98 /

-0.21 (-1.88%)

General news
FX Action: The dollar » 08:45
05/06/21
05/06
08:45
05/06/21
08:45
$ECON

Economic Data

/

+

FX Action: The dollar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    Recommendations
    Fastly price target lowered to $85 from $110 at Oppenheimer » 08:44
    05/06/21
    05/06
    08:44
    05/06/21
    08:44
    FSLY

    Fastly

    $57.98 /

    -1.3 (-2.19%)

    Oppenheimer analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    FSLY Fastly
    $57.98 /

    -1.3 (-2.19%)

    FSLY Fastly
    $57.98 /

    -1.3 (-2.19%)

    06:04 Today Piper Sandler
    Fastly price target lowered to $45 from $65 at Piper Sandler
    04/28/21
    Fly Intel: Top five analyst downgrades
    04/28/21 Raymond James
    Fastly downgraded to Market Perform from Outperform at Raymond James
    04/27/21 Raymond James
    Fastly downgraded to Market Perform from Outperform at Raymond James
    FSLY Fastly
    $57.98 /

    -1.3 (-2.19%)

    • 21
      May
    FSLY Fastly
    $57.98 /

    -1.3 (-2.19%)

    FSLY Fastly
    $57.98 /

    -1.3 (-2.19%)

    FSLY Fastly
    $57.98 /

    -1.3 (-2.19%)

    Recommendations
    Match Group price target raised to $165 from $160 at Oppenheimer » 08:43
    05/06/21
    05/06
    08:43
    05/06/21
    08:43
    MTCH

    Match Group

    $143.67 /

    +4.5102 (+3.24%)

    Oppenheimer analyst Jason…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    MTCH Match Group
    $143.67 /

    +4.5102 (+3.24%)

    MTCH Match Group
    $143.67 /

    +4.5102 (+3.24%)

    08:31 Today KeyBanc
    Match Group price target raised to $172 from $165 at KeyBanc
    04/12/21
    Fly Intel: Top five analyst upgrades
    04/12/21 BTIG
    Match Group upgraded to Buy at BTIG given pullback in stock price
    04/12/21 BTIG
    Match Group upgraded to Buy from Neutral at BTIG
    MTCH Match Group
    $143.67 /

    +4.5102 (+3.24%)

    MTCH Match Group
    $143.67 /

    +4.5102 (+3.24%)

    MTCH Match Group
    $143.67 /

    +4.5102 (+3.24%)

    MTCH Match Group
    $143.67 /

    +4.5102 (+3.24%)

    Recommendations
    HubSpot price target raised to $600 from $525 at Jefferies » 08:42
    05/06/21
    05/06
    08:42
    05/06/21
    08:42
    HUBS

    HubSpot

    $505.82 /

    +6.925 (+1.39%)

    Jefferies analyst Samad…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    HUBS HubSpot
    $505.82 /

    +6.925 (+1.39%)

    HUBS HubSpot
    $505.82 /

    +6.925 (+1.39%)

    08:27 Today BMO Capital
    HubSpot price target raised to $585 from $565 at BMO Capital
    07:59 Today Canaccord
    HubSpot price target raised to $580 from $560 at Canaccord
    07:40 Today Morgan Stanley
    HubSpot price target raised to $605 from $567 at Morgan Stanley
    07:27 Today Needham
    HubSpot price target raised to $600 from $520 at Needham
    HUBS HubSpot
    $505.82 /

    +6.925 (+1.39%)

    HUBS HubSpot
    $505.82 /

    +6.925 (+1.39%)

    HUBS HubSpot
    $505.82 /

    +6.925 (+1.39%)

    Hot Stocks
    AMMO, Mill City Ventures III partner on GunBroker.com customer financing » 08:42
    05/06/21
    05/06
    08:42
    05/06/21
    08:42
    POWW

    AMMO

    $6.78 /

    -0.155 (-2.24%)

    AMMO is pleased to…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    POWW AMMO
    $6.78 /

    -0.155 (-2.24%)

    POWW AMMO
    $6.78 /

    -0.155 (-2.24%)

    04/22/21
    Fly Intel: Top five analyst initiations
    04/22/21 Lake Street
    AMMO initiated with a Buy at Lake Street
    04/08/21 Roth Capital
    AMMO initiated with a Buy at Roth Capital
    POWW AMMO
    $6.78 /

    -0.155 (-2.24%)

    • 12
      Mar
    • 01
      Dec
    POWW AMMO
    $6.78 /

    -0.155 (-2.24%)

    POWW AMMO
    $6.78 /

    -0.155 (-2.24%)

    Recommendations
    Etsy price target lowered to $200 from $240 at Oppenheimer » 08:42
    05/06/21
    05/06
    08:42
    05/06/21
    08:42
    ETSY

    Etsy

    $184.42 /

    -4.04 (-2.14%)

    Oppenheimer analyst Jason…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    ETSY Etsy
    $184.42 /

    -4.04 (-2.14%)

    ETSY Etsy
    $184.42 /

    -4.04 (-2.14%)

    08:38 Today Truist
    Etsy price target lowered to $215 from $224 at Truist
    08:31 Today Morgan Stanley
    Etsy price target raised to $135 from $123 at Morgan Stanley
    07:36 Today BTIG
    Etsy price target lowered to $215 from $235 at BTIG
    04/26/21
    Fly Intel: Top five analyst downgrades
    ETSY Etsy
    $184.42 /

    -4.04 (-2.14%)

    ETSY Etsy
    $184.42 /

    -4.04 (-2.14%)

    ETSY Etsy
    $184.42 /

    -4.04 (-2.14%)

    ETSY Etsy
    $184.42 /

    -4.04 (-2.14%)

    Hot Stocks
    Tapestry sees 'mild' impact on Q4 results from Suez Canal blockage  08:40
    05/06/21
    05/06
    08:40
    05/06/21
    08:40
    TPR

    Tapestry

    $48.40 /

    +0.405 (+0.84%)

     
    ShowHide Related Items >><<
    TPR Tapestry
    $48.40 /

    +0.405 (+0.84%)

    TPR Tapestry
    $48.40 /

    +0.405 (+0.84%)

    05/03/21 Deutsche Bank
    Tapestry price target raised to $54 from $45 at Deutsche Bank
    04/15/21 OTR Global
    Tapestry upgraded to Positive from Mixed at OTR Global
    04/07/21 Piper Sandler
    Tapestry price target raised to $54 from $45 at Piper Sandler
    03/05/21 BMO Capital
    Tapestry price target raised to $45 from $36 at BMO Capital
    TPR Tapestry
    $48.40 /

    +0.405 (+0.84%)

    TPR Tapestry
    $48.40 /

    +0.405 (+0.84%)

    TPR Tapestry
    $48.40 /

    +0.405 (+0.84%)

    Hot Stocks
    Generex's NuGenHealth contracts with FHCA to provide remote patient monitoring » 08:40
    05/06/21
    05/06
    08:40
    05/06/21
    08:40
    GNBT

    Generex

    /

    +

    Generex announces that…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    GNBT Generex
    /

    +

    Recommendations
    Anthem price target raised to $435 from $330 at Argus » 08:40
    05/06/21
    05/06
    08:40
    05/06/21
    08:40
    ANTM

    Anthem

    /

    +

    Argus analyst Jasper…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    ANTM Anthem
    /

    +

    ANTM Anthem
    /

    +

    05/04/21 Piper Sandler
    Teladoc closed down 5% on three year old 'news,' says Piper Sandler
    05/03/21 Mizuho
    Anthem price target raised to $380 from $320 at Mizuho
    04/28/21 Morgan Stanley
    Centene didn't meet 'high bar' set by peers, says Morgan Stanley
    04/22/21 Stephens
    Anthem price target raised to $430 from $395 at Stephens
    ANTM Anthem
    /

    +

    ANTM Anthem
    /

    +

    ANTM Anthem
    /

    +

    ANTM Anthem
    /

    +

    Initiation
    Tilray merger with Aphria completed, Canaccord initiates with Hold » 08:40
    05/06/21
    05/06
    08:40
    05/06/21
    08:40
    TLRY

    Tilray

    $15.91 /

    -0.16 (-1.00%)

    as reported previously,…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    TLRY Tilray
    $15.91 /

    -0.16 (-1.00%)

    TLRY Tilray
    $15.91 /

    -0.16 (-1.00%)

    05:59 Today Canaccord
    Tilray initiated with a Buy at Canaccord
    04/28/21 BofA
    Tilray reinstated with a Buy at BofA
    04/13/21 Canaccord
    Aphria downgraded to Hold on industry headwinds at Canaccord
    04/06/21 Stifel
    Aphria price target raised to C$22 from C$15.50 at Stifel
    TLRY Tilray
    $15.91 /

    -0.16 (-1.00%)

    TLRY Tilray
    $15.91 /

    -0.16 (-1.00%)

    TLRY Tilray
    $15.91 /

    -0.16 (-1.00%)

    TLRY Tilray
    $15.91 /

    -0.16 (-1.00%)

    Hot Stocks
    Tapestry expects to incur higher freight costs  08:40
    05/06/21
    05/06
    08:40
    05/06/21
    08:40
    TPR

    Tapestry

    $48.40 /

    +0.405 (+0.84%)

     
    ShowHide Related Items >><<
    TPR Tapestry
    $48.40 /

    +0.405 (+0.84%)

    TPR Tapestry
    $48.40 /

    +0.405 (+0.84%)

    05/03/21 Deutsche Bank
    Tapestry price target raised to $54 from $45 at Deutsche Bank
    04/15/21 OTR Global
    Tapestry upgraded to Positive from Mixed at OTR Global
    04/07/21 Piper Sandler
    Tapestry price target raised to $54 from $45 at Piper Sandler
    03/05/21 BMO Capital
    Tapestry price target raised to $45 from $36 at BMO Capital
    TPR Tapestry
    $48.40 /

    +0.405 (+0.84%)

    TPR Tapestry
    $48.40 /

    +0.405 (+0.84%)

    TPR Tapestry
    $48.40 /

    +0.405 (+0.84%)

    Hot Stocks
    ProPhase Labs to provide COVID testing to Dutchess County, New York » 08:40
    05/06/21
    05/06
    08:40
    05/06/21
    08:40
    PRPH

    ProPhase Labs

    $5.20 /

    +0.05 (+0.97%)

    ProPhase Labs announced…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    PRPH ProPhase Labs
    $5.20 /

    +0.05 (+0.97%)

    PRPH ProPhase Labs
    $5.20 /

    +0.05 (+0.97%)

    01/20/21 Dawson James
    ProPhase Labs initiated with a Buy at Dawson James
    PRPH ProPhase Labs
    $5.20 /

    +0.05 (+0.97%)

    PRPH ProPhase Labs
    $5.20 /

    +0.05 (+0.97%)

    PRPH ProPhase Labs
    $5.20 /

    +0.05 (+0.97%)

    Recommendations
    Neurocrine price target lowered to $140 from $145 at Oppenheimer » 08:39
    05/06/21
    05/06
    08:39
    05/06/21
    08:39
    NBIX

    Neurocrine

    $91.67 /

    +0.05 (+0.05%)

    Oppenheimer analyst Jay…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    NBIX Neurocrine
    $91.67 /

    +0.05 (+0.05%)

    NBIX Neurocrine
    $91.67 /

    +0.05 (+0.05%)

    06:39 Today Mizuho
    Neurocrine price target lowered to $98 from $116 at Mizuho
    06:12 Today Barclays
    Neurocrine upgraded to Overweight from Equal Weight at Barclays
    04/26/21 Mizuho
    Neurocrine price target lowered to $116 from $119 at Mizuho
    04/26/21 Mizuho
    Neurocrine price target lowered to $116 from $119 at Mizuho
    NBIX Neurocrine
    $91.67 /

    +0.05 (+0.05%)

    NBIX Neurocrine
    $91.67 /

    +0.05 (+0.05%)

    Earnings
    Wayfair sees Q2 revenue higher than Q1, consensus $4.03B » 08:39
    05/06/21
    05/06
    08:39
    05/06/21
    08:39
    W

    Wayfair

    $270.95 /

    -3.05 (-1.11%)

    Sees Q2 gross margin…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    W Wayfair
    $270.95 /

    -3.05 (-1.11%)

    W Wayfair
    $270.95 /

    -3.05 (-1.11%)

    05/03/21 Jefferies
    Wayfair Q1 sales estimates boosted at Jefferies after 'record-breaking' Way Day
    04/19/21 Loop Capital
    Wayfair price target raised to $340 from $290 at Loop Capital
    04/09/21 Piper Sandler
    Wayfair price target raised to $420 from $370 at Piper Sandler
    03/31/21 DA Davidson
    Wayfair price target raised to $450 from $326 at DA Davidson
    W Wayfair
    $270.95 /

    -3.05 (-1.11%)

    W Wayfair
    $270.95 /

    -3.05 (-1.11%)

    W Wayfair
    $270.95 /

    -3.05 (-1.11%)

    W Wayfair
    $270.95 /

    -3.05 (-1.11%)

    Earnings
    U.S. Physical Therapy reports Q1 EPS 64c, consensus 47c » 08:39
    05/06/21
    05/06
    08:39
    05/06/21
    08:39
    USPH

    U.S. Physical Therapy

    $112.45 /

    -3.35 (-2.89%)

    Reports Q1 revenue…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    USPH U.S. Physical Therapy
    $112.45 /

    -3.35 (-2.89%)

    USPH U.S. Physical Therapy
    $112.45 /

    -3.35 (-2.89%)

    05/03/21 Jefferies
    U.S. Physical Therapy upgraded to Buy from Hold at Jefferies
    02/26/21 Barrington
    U.S. Physical Therapy downgraded to Market Perform from Outperform at Barrington
    10/28/20 Barrington
    Varian Medical downgraded to Underperform from Outperform at Barrington
    08/07/20 Barrington
    U.S. Physical Therapy price target raised to $100 from $95 at Barrington
    USPH U.S. Physical Therapy
    $112.45 /

    -3.35 (-2.89%)

    Recommendations
    Tandem Diabetes price target raised to $135 from $130 at Oppenheimer » 08:38
    05/06/21
    05/06
    08:38
    05/06/21
    08:38
    TNDM

    TNDM

    /

    +

    Oppenheimer analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    TNDM TNDM
    /

    +

    TNDM TNDM
    /

    +

    05:00 Today Piper Sandler
    Tandem Diabetes remains a 'name to buy' after Q1 beat, says Piper Sandler
    03/12/21 Piper Sandler
    Tandem Diabetes competition concerns overblown, says Piper Sandler
    02/25/21 Lake Street
    Tandem Diabetes price target raised to $150 from $137 at Lake Street
    02/04/21 Piper Sandler
    Tandem trades at 'significant discount' to Insulet, says Piper Sandler
    TNDM TNDM
    /

    +

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.